SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 148 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $298,563 | +12.5% | 311,003 | -12.1% | 0.00% | – |
| Q1 2023 | $265,428 | +120.3% | 353,904 | +8.3% | 0.00% | – |
| Q4 2022 | $120,465 | -14.6% | 326,906 | -0.4% | 0.00% | – |
| Q3 2022 | $141,000 | -44.7% | 328,278 | +0.2% | 0.00% | – |
| Q2 2022 | $255,000 | -86.6% | 327,751 | -77.7% | 0.00% | – |
| Q1 2022 | $1,899,000 | -11.6% | 1,472,567 | -12.9% | 0.00% | – |
| Q4 2021 | $2,147,000 | -46.3% | 1,691,151 | -7.7% | 0.00% | -100.0% |
| Q3 2021 | $3,995,000 | -42.7% | 1,832,302 | -1.5% | 0.00% | 0.0% |
| Q2 2021 | $6,977,000 | +31.0% | 1,860,874 | +13.9% | 0.00% | 0.0% |
| Q1 2021 | $5,325,000 | -8.0% | 1,633,550 | -3.8% | 0.00% | 0.0% |
| Q4 2020 | $5,790,000 | -16.7% | 1,697,658 | -0.3% | 0.00% | -50.0% |
| Q3 2020 | $6,950,000 | +42.2% | 1,703,349 | +17.8% | 0.00% | +100.0% |
| Q2 2020 | $4,886,000 | +43.7% | 1,445,792 | -0.9% | 0.00% | 0.0% |
| Q1 2020 | $3,400,000 | -36.7% | 1,459,309 | -1.2% | 0.00% | 0.0% |
| Q4 2019 | $5,373,000 | -55.2% | 1,476,441 | +2.2% | 0.00% | -66.7% |
| Q3 2019 | $11,981,000 | +7.8% | 1,444,419 | +11.9% | 0.00% | 0.0% |
| Q2 2019 | $11,112,000 | -17.8% | 1,290,560 | +2.1% | 0.00% | 0.0% |
| Q1 2019 | $13,516,000 | +23.0% | 1,264,309 | +0.7% | 0.00% | 0.0% |
| Q4 2018 | $10,986,000 | -50.7% | 1,255,410 | -5.3% | 0.00% | -40.0% |
| Q3 2018 | $22,265,000 | -16.0% | 1,325,256 | +4.9% | 0.01% | -28.6% |
| Q2 2018 | $26,492,000 | +52.7% | 1,263,899 | +17.2% | 0.01% | +40.0% |
| Q1 2018 | $17,345,000 | -14.7% | 1,078,050 | +0.5% | 0.01% | 0.0% |
| Q4 2017 | $20,332,000 | +46.4% | 1,072,970 | +8.7% | 0.01% | +25.0% |
| Q3 2017 | $13,891,000 | +91.0% | 987,290 | +1.2% | 0.00% | +100.0% |
| Q2 2017 | $7,271,000 | +12.0% | 975,977 | -2.3% | 0.00% | 0.0% |
| Q1 2017 | $6,494,000 | +56.5% | 999,075 | +6.6% | 0.00% | +100.0% |
| Q4 2016 | $4,150,000 | +2.7% | 936,942 | +8.3% | 0.00% | 0.0% |
| Q3 2016 | $4,041,000 | -19.8% | 865,342 | +12.8% | 0.00% | -50.0% |
| Q2 2016 | $5,041,000 | +1.8% | 767,398 | -1.4% | 0.00% | 0.0% |
| Q1 2016 | $4,952,000 | +11.2% | 778,462 | +5.5% | 0.00% | +100.0% |
| Q4 2015 | $4,452,000 | +4.9% | 738,209 | +4.0% | 0.00% | 0.0% |
| Q3 2015 | $4,246,000 | -12.6% | 710,093 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $4,860,000 | +11.5% | 710,516 | -1.0% | 0.00% | 0.0% |
| Q1 2015 | $4,359,000 | -13.4% | 718,050 | -1.1% | 0.00% | -50.0% |
| Q4 2014 | $5,031,000 | -17.1% | 725,979 | -2.6% | 0.00% | 0.0% |
| Q3 2014 | $6,067,000 | -0.5% | 745,340 | -0.7% | 0.00% | 0.0% |
| Q2 2014 | $6,099,000 | -8.8% | 750,226 | -12.0% | 0.00% | 0.0% |
| Q1 2014 | $6,684,000 | -17.6% | 852,645 | -7.0% | 0.00% | -33.3% |
| Q4 2013 | $8,115,000 | -1.0% | 916,983 | -6.3% | 0.00% | 0.0% |
| Q3 2013 | $8,200,000 | +18.1% | 978,494 | +5.1% | 0.00% | 0.0% |
| Q2 2013 | $6,945,000 | – | 930,963 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |